Column in Biological Technology

New Capillary Column From Varian, Inc. Offers Durability and Performance for High Temperature GC and GC/MS

... column lifetime with excellent peak shape and low column bleed for the best detection limits at high temperatures. The UltiMetal column is a high performance, lasting solution for high ... and crown ethers. The VF-5ht UltiMetal column is the latest addition to Varian's ...

Waters Corporation Continues to Meet Today's Challenges for Improved Laboratory Operations with New Products at Pittcon 2009

... mobility research-grade mass spectrometers ; more than 50 column configurations and chemistries including newly-redeveloped ACQUITY UPLC ... novel microfluidic separation technology with Waters' sub two-micron column chemistries, unique solvent delivery and comprehensive data management for ...

Bio-Matrix Scientific Group Featured as 'Stock Pick' in Oakley's Column on WallStreetCorner.com

... ( http://wallstreetcorner.com/stockpick.html ), an editorial column that along with his Conservative Speculator Newsletter and Special ... shares and a market cap of $7.57 million." Mr. Oakley's "Stock Pick" column describes BMSN's recently opened commercial cryogenic banking and stem ...

Supelco(R) Expands Ascentis(R) Express HPLC Columns Line for High-Speed and High-Efficiency Separations

... bonding chemistry and the Fused-Core(TM) particle provides a polar column for high-speed and high-resolution separations," said Wayne K. Way, ... shape for basic compounds." The key technology in the Ascentis Express column is the Fused-Core particle. These high-purity silica particles measure 2.7 ...

Karl Strauss and GreenHouse Partner to Create Alternative Fuel from Beer Waste

... windows. The E-Fuel100 MicroFueler™ is the world's first portable ethanol micro-refinery system; it replaces the traditional ethanol reflux column system with a solid state distillation technology, making it possible for homeowners and small businesses to safely and cost-effectively create their ...

NeoStem Featured in Business Week; 'Promising' Adult Stem Cell Market Discussed in Fortune-CNNMoney.com Article

... Chinese provinces of Jiangsu, Zhejiang, Fujian, Anhui and Jiangxi using NeoStem's proprietary technologies. To read the "Inside Wall Street" column taking the above into account please use the following link: ...

GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business

... by 2012 with integration costs of approximately $325 million over the next 3 years. These integration costs will be reported within the middle column of GSK's income statement together with other ongoing major restructuring costs. Excluding integration costs, the transaction is expected to result ...

General Patent Corporation Calls New Patent Reform Bill Harmful to Inventors and Entrepreneurs

... N.Y., (PRWEB) - General Patent Corporation chairman and CEO Alexander Poltorak, writing in the popular syndicated "Washington Watch" column circulated throughout the country, strongly criticized the proposed Patent Reform Act of 2009, and said that "recycling a piece of failed ...

Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S

... Kits: We were the first company in the world to develop kits for the purification of RNA/DNA/Proteins (3-in-1) sequentially from a single column without any sample splitting. And the 4-in-1 kit where one can sequentially isolate proteins, DNA, RNA, and microRNA using a single column, ...

New Gas Clean Filter Technology From Varian, Inc. Reduces Contamination in GC, ICP and GC/MS

... filters are positioned in the gas line between the compressed gas cylinders and the instrument. Reducing contamination in the gas reduces the risk of column damage. With the filters in place, chemists can save money by using less expensive, lower grade gases and still get the results they require. For ...

Edmonton's Technology Community: Using Social Media to Raise Awareness

... of the Visionaries project, Edmontonians publishes profiles and briefs showcasing local innovators, their discoveries and their products. Schwabe's column on social media appears monthly. "Edmonton has an amazing variety of successful technology companies that get no attention and we're hoping ...

Ameristar National Charity Golf Classic Raises More Than $1.1 Million for Buoniconti Fund to Cure Paralysis and Christopher & Dana Reeve Foundation

... spinal cord" by The Miami Project's Dr. Green, the treatment was credited with reducing swelling and minimizing further damage to Everett's spinal column in an injury that could have left him paralyzed. He was walking again within a few months of his accident. "The type of injury Kevin suffered is ...

New Safe Lifting Patient Safety Resource for Nursing School Educators and Students

... projected savings using an interactive return-on-investment calculator. It also includes a monthly electronic newsletter and a question-and-answer column called "Ask the Lift Doctor." To access the Nursing School section of Safe Lifting Portal, visit http://www.safeliftingportal.com/nursing-schools/ ...

New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum.

... for users in applications from electron microscopy to high energy physics. For example, the TPS-compact is ideal for maintaining vacuum in the column of an electron microscope during servicing or ensuring purity when evacuating load-lock chambers for semiconductor manufacturing. Additionally, the ...

Adoption of Spinal Nonfusion Technologies Doubled in One Year

... of physiological vertebral motion through proper intervertebral spacing and stability. Dynamic stabilization is intended to achieve posterior column stabilization devoid of fusion and without the manipulation of intervertebral discs or facet joints. This ensures that stability is established with ...

Citrate appears to control buckyball clumping but environmental concerns remain

... professor and TEM lab director Joerg R. Jinschek Future environmental research will be done with simulated subsurface environments using a sand column to determine how these acidified masses move in ground water. Vikesland will present Changs and his research about how C 60 and citric acid ...

WallSt.net Announces Upcoming Interview With CEO of Biomoda

... appropriate exchange at the top of the "Interviews" section or by entering the company's ticker symbol in the Search Archive window on the right-hand column of the "Interviews" section. About Biomoda: Biomoda is committed to the vision that the early detection of cancer is achievable in our lifetime. ...

WallSt.net Announces Upcoming Interview with CEO of BioSante Pharmaceuticals

... appropriate exchange at the top of the "Interviews" section or by entering the company's ticker symbol in the Search Archive window on the right-hand column of the "Interviews" section once it is posted. About BioSante Pharmaceuticals, Inc. BioSante is developing a pipeline of hormone therapy products ...

WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics

... at the top of the "Interviews" section of the site, or by entering the company's ticker symbol in the Search Archive window on the right-hand column of the "Interviews" section. About DNAPrint Genomics: DNAPrint(TM) Genomics, Inc. is a developer of genomics-based products and services in two ...

WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of Osteologix

... at the top of the "Interviews" section of the site, or by entering the company's ticker symbol in the Search Archive window on the right-hand column of the "Interviews" section once it is posted. About Osteologix: Osteologix develops pharmaceutical products for bone and cartilage disorders ...

More Midwest Seed-Stage Life Science VCs

... science companies off the ground. This weeks column will try to knit together some of these pieces so the tapestry doesnt fall apart. Last weeks column evoked responses from a number of readers who ... or Iowa in this review. If any readers of this column are aware of other groups, please let me know and ...

Midwest small-cap life sciences turn in mixed third-quarter results

... what transpired. For those of you who follow this column regularly, you will note some changes in the ... Midwest and U.S. biotech. Disclaimer: This column is not a communication to provide incentive to ... expressed herein or statements made in the above column are solely those of the author, & do not ...

What to do when dining with a Jive Turkey technology job candidate

... Sometimes in this column we write about very unprofessional, clueless or ... can be e-mailed at lizryan@worldwit.org . Her column Nine2Five, which appears on ePrairie every ... expressed herein or statements made in the above column are solely those of the author, & do not ...

Last-minute stocking stuffers

... . And to all a good night: This is the last column from me this year, so until Jan. 3, may you have ... . This column was reprinted with permission of Network World ... expressed herein or statements made in the above column are solely those of the author, & do not ...

The myth of objectivity

... I was going to write todays column about a toilet seat. Seriously. The Brondell ... . This column was reprinted with permission of Network World ... expressed herein or statements made in the above column are solely those of the author, & do not ...

Midwest is cost-effective for startup biotech companies

... In May 2003, I wrote a column about the cost of doing business (CODB) for ... parts of the United States. The point of the column was that one of the advantages of doing business ... ability to raise VC money. When I started this column back in February 2003, I did so under the firm ...

Readers react to 'Cingular confusion'

... as much as a poor customer experience. No column I've written in the last three years has drawn as ... . This column was reprinted with permission of Network World ... expressed herein or statements made in the above column are solely those of the author, & do not ...

Midwest Venture Summit disappoints; Cato grades Midwest governors

... about the overall quality of the presenters, this column offers you a platform to opine . Grading the ... tank. Perhaps this is related to John Fund's column in the Wall Street Journal about Germany's ... expressed herein or statements made in the above column are solely those of the author, & do not ...

Line between big pharma, big biotech continues to blur

... market valuation has been the subject of a prior column and can mostly be attributed to the market ... Of course, anyone who has been reading this column for a while knows that it will take place in ... expressed herein or statements made in the above column are solely those of the author and do not ...

U.K. firm develops smart fabrics

... ElekTex as soft controls into the steering column of automobiles. Virtual reality game developers ... . This column was reprinted with permission of Network World ... expressed herein or statements made in the above column are solely those of the author, & do not ...

Declaring independence from technology (sort of)

... to complicate matters. I decided that this week's column would be a Declaration of Independence from the ... . This column was reprinted with permission of Network World ... expressed herein or statements made in the above column are solely those of the author, & do not ...

Lamenting the loss of leisure

... Last weeks column spurred enough e-mail to suggest that I was ... . This column was reprinted with permission of Network World ... expressed herein or statements made in the above column are solely those of the author, & do not ...

Leaving it all behind

... may be a cheap question designed to wrap up this column and get out on the playing field, but I really do ... This column was reprinted with permission of Network World ... expressed herein or statements made in the above column are solely those of the author, & do not ...

Midwest biotech on a roll

... Greatest rock guitarists redux My previous column on the above subject produced such a furor of ... poll, I continued my search after I wrote the column to find a more definitive and perhaps ... expressed herein or statements made in the above column are solely those of the author and do not ...

Midwest biotech stocks drop like a rock during the third quarter

... Stocks Dropping Like a Rock Last weeks column focused on the performance of the Midwest large ... of life. See you next week! Disclaimer: This column is not a communication to provide incentive to ... expressed herein or statements made in the above column are solely those of the author and do not ...

Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says

... CHICAGO Anyone following this column over the last few years knows about my propensity ... were always nebulous to me. Naturally, this column will contain two lists: a biotech one and a ... expressed herein or statements made in the above column are solely those of the author and do not ...

Can we prevent Web 2.0 from being a bubble?

... Last weeks column sure hit a nerve. I heard from a number of ... When will we become blind to a right-hand column full of advertising, no matter how relevant to ... . This column was reprinted with permission of Network World ...

2005: the year of the comeback

... The last column of the year is an invitation for reflection, and ... 2005, what do you see? Im taking a break from column writing the next couple of weeks, so I look ... . This column was reprinted with permission of Network World ...

The DEMO Summer Reading List

... summer reading books that will at least fill this column and most certainly give you something ... . This column was reprinted with permission of Network World ... expressed herein or statements made in the above column are solely those of the author, and do not ...